Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/23 17:00 | 10/27/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | Nelson Sonja | CA | O | CFO | S | -125 | 9.82 | 0 | -13 | -9 | 130 | D | ||||||||||||||
10/31/23 17:00 | 10/27/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | O'Connor Daniel J. | CA | DO | P,CEO | S | -491 | 9.82 | 0 | -50 | -13 | 343 | D | ||||||||||||||
10/25/23 16:15 | 10/23/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | T | P | 9,140 | 6.99 | 0 | 1,307 | 13 | 11,231 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |